Skip to contentS
Sensus Healthcare, Inc.
S
SRTSSensus Healthcare, Inc. Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$5.10M$5.10Mderived−40.1% vs Q4 2019 Net Income$1.02M$1.02Mderived−2.0% vs Q4 2019 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sensus Healthcare, Inc. · CIK 1494891 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$3,228,561−40.8% Operating Incomederived$257,360−73.9% Operating Cash Flowderived-$360,419N/M Free Cash Flowderived-$464,101N/M Margins · derivedGross margin63.4%−0.8 pt vs Q4 2019
Operating margin5.1%−6.5 pt vs Q4 2019
Net margin20.0%+7.8 pt vs Q4 2019
ended Dec 31, 2020 · filed Mar 5, 2021 · 64 d after period end